Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Glenmark Pharmaceuticals secures US FDA approval for Clindamycin Phosphate Foam, 1% generic Glenmark Pharmaceuticals wins US FDA approval for its generic Clindamycin Phosphate Foam, 1%, expanding its US dermatology portfolio with a new acne treatment option. bySrinathSeptember 21, 2021